Sawgrass Asset Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-90,927	Closed	-$12.5M	–	183
2024 Q2	$12.5M	Sell	90,927 -1,545	-2%	-$213K	1.36%	23
2024 Q1	$12.8M	Sell	92,472 -7,085	-7%	-$977K	1.4%	22
2023 Q4	$13.1M	Buy	+99,557	New	+$13.1M	1.48%	21